Milos Budisavljevic, MD

Habib G. Rizk, M.D., MSc grew up in Beirut-Lebanon. He attended the French Faculty of Medicine-Saint Joseph University in Beirut Lebanon and pursued an Otolaryngology – Head & Neck Surgery residency at Hôtel-Dieu de France Hospital in Beirut followed by a one-year Otologic Medicine and Surgery Fellowship under the mentorship of Dr. Michael Teixido and a two-year Neurotology fellowship at the Medical University of South Carolina. Dr. Rizk's interests pertain to all areas of otology and neurotology with a specific focus on medical and surgical management of vestibular disorders. He is an associate professor in the MUSC department of Otolaryngology, Head & Neck Surgery, and is the Director of the Multidisciplinary Vestibular Program. Dr. Rizk is currently on the board of directors and is vice-president of the Vestibular Disorders Association. He is a member of the Bárány society and a fellow of the American Neurotology Society. He is also a member of the American Balance Society and of the Otology and Neurotology Education Committee of the American Academy of Otolaryngology-Head and Neck Surgery.

Patrick Flume is a Distinguished Professor of Medicine and Pediatrics at the Medical University of South Carolina. He serves as the Powers-Huggins Endowed Chair for Cystic Fibrosis and oversees a large Cystic Fibrosis (CF) Center, including the largest adult CF program in South Carolina. He also leads large clinical programs dedicated to patients with bronchiectasis and non-tuberculous mycobacterial (NTM) infections. He is recognized by the national and international CF community having served on the CF Foundation Center Committee, the Adult Care Consensus Committee, and the Advisory Task Force on Adult Issues, the Professional Education Committee, the European CF Society’s Best Practices committee, and as founding co-chair of the CF Foundation’s Pulmonary Practice Guidelines Committee. He co-led the International Working Group on Antimicrobial Resistance in Cystic Fibrosis. He is the Editor-in-Chief for the Journal of Cystic Fibrosis. He serves as Associate Vice President for Clinical Research at MUSC, leads a very busy clinical research program for CF, bronchiectasis, and NTM, and is co-principal investigator for the South Carolina Clinical & Translational Research Institute. Many of these studies are related to new drug and therapy development for patients, but he also has an interest in determining optimal management of CF pulmonary exacerbations and is the co-PI in the STOP trials, aimed at identifying optimal treatments for exacerbations.

This provider is a board-certified internist who only sees patients ages 18 and older. If the patient is under 18 years of age, please select a different primary care provider. We apologize for any inconvenience. Dr. Elisha Brownfield is an associate professor of medicine at the Medical University of South Carolina. She received her medical degree from the Medical College of Virginia, and completed an internal medicine residency at the Bowman-Gray School of Medicine/North Carolina Baptist Hospital.Dr. Brownfield is a member of the Society of General Internal Medicine and has served as the president of this group's southern region. She is a fellow of the American College of Physicians and a member of the Association of Program Directors of Internal Medicine. She has been chosen as one of the Best Doctors of America on multiple occasions. Her interests include medical education and leadership development.